Vor Biopharma Inc. · NASDAQ:VOR
Great Point Partners LLC reported a 5.63% stake in Vor Biopharma Inc. (Schedule 13G)
Event Dec 10, 2025 · Filed Dec 17, 2025
Great Point Partners LLC reported a 5.63% stake in Vor Biopharma Inc., 1,234,486 shares, as a passive investor on Dec 10, 2025. Filed Dec 17, 2025 (Schedule 13G).
- Stake
- 5.63%
- Shares
- 1,234,486
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Great Point Partners, LLC | 5.63% | 1,234,486 |
| Dr. Jeffrey R. Jay, M.D. | 5.63% | 1,234,486 |
| Ms. Lillian Nordahl | 5.63% | 1,234,486 |
Source
Related
- Vor Biopharma Inc.
- Great Point Partners LLC
- Vor Biopharma Inc. shareholders
- Schedule 13G/A · Great Point Partners LLC · Feb 17, 2026
- Form 4 · Ra Capital Management, L.P. · Oct 5, 2026
- Form 4 · RA Capital Healthcare Fund LP · Aug 26, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Verve Capital Limited · Aug 13, 2026